About neoSurgical
neoSurgical is a company based in Galway (Ireland) founded in 2008 was acquired by Sharp Fluidics in April 2020. neoSurgical has raised $13.26 million across 3 funding rounds from investors including Enterprise Ireland, Sharp Fluidics and Targeted Technology. neoSurgical operates in a competitive market with competitors including Olympus, Eximis Surgical, SurgiQuest, New View Surgical and Xenocor, among others.
- Headquarter Galway, Ireland
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neosurgical Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.26 M (USD)
in 3 rounds
-
Latest Funding Round
$5.5 M (USD), Series B
Jun 06, 2017
-
Investors
Enterprise Ireland
& 3 more
-
Employee Count
Not available
-
Acquired by
Sharp Fluidics
(Apr 07, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of neoSurgical
neoSurgical has successfully raised a total of $13.26M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $5.5 million completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in neoSurgical
neoSurgical has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Enterprise Ireland, Sharp Fluidics and Targeted Technology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage investments in medical and life science technologies are made by Targeted Technology.
|
Locked | Locked | Locked | |
|
VC firm investing in the UK and the US
|
Locked | Locked | Locked | |
|
Support is provided to Irish manufacturing and service sector businesses.
|
Locked | Locked | Locked |
Investor details for neoSurgical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by neoSurgical
Investment portfolio details for neoSurgical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - neoSurgical
Detailed financials for neoSurgical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neosurgical Comparisons
Peer comparison for neoSurgical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of neoSurgical
neoSurgical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Olympus, Eximis Surgical, SurgiQuest, New View Surgical and Xenocor, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Manufacturer of imaging and surgical products
|
|
| Locked | Locked | Locked |
Minimal invasive specimen removal tools
|
|
| Locked | Locked | Locked |
Products for minimally invasive surgery are developed and supplied.
|
|
| Locked | Locked | Locked |
Minimally invasive systems for laparoscopic surgery are developed.
|
|
| Locked | Locked | Locked |
Laparoscopic imaging systems for surgical applications are provided.
|
|
| Locked | Locked | Locked |
Patented laparoscopic instruments are designed, manufactured, and distributed.
|
Detailed competitors of neoSurgical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neosurgical
Complete news archive for neoSurgical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about neoSurgical
neoSurgical was founded in 2008 and raised its 1st funding round 3 years after it was founded.
neoSurgical is headquartered in Galway, Ireland.
neoSurgical is a funded company, having raised a total of $13.26M across 3 funding rounds to date.
neoSurgical was founded in 2008 in Galway, Ireland, as a provider of medical devices in the surgical sector. Laparoscopic instruments are developed and supplied, with the lead product neoClose utilized for port site closure after abdominal procedures. Additional devices support access and retraction during laparoscopic surgeries. Operations focus on instrument innovation for minimally invasive techniques in healthcare settings.
neoSurgical's top competitors include Olympus, New View Surgical and SurgiQuest.
neoSurgical has 4 investors. Key investors include Enterprise Ireland, Sharp Fluidics, Targeted Technology, and Kernel Capital.
The valuation of neoSurgical is $21M as of Apr 2015.